Delivered as a Hybrid Event
April 28-30, 2025The Ritz-Carlton, Tysons Corner | McLean, VAKey Sessions
Robert Ladd
Becoming High-Impact Business Partners: Strategic Relationships with Internal Stakeholders
Gilead Sciences
Anisa Dhalla
Global CCO Spotlight: An International Dialogue and Discussion on Compliance and Risk
UCB
Joseph Philipose
Compliance’s Role in Evolving Privacy Regulation Landscape
Emergent BioSolutions
Christine Zettlemoyer
How to Leverage AI in Compliance Function
Genmab
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 2 - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day 2 - ET (Eastern Time, GMT-05:00)
search
Streams
Formats
7:30am - 8:30am
Conference Registration and Continental Breakfast
Showing 1 of 1 Streams
Main Stage
8:30am - 8:40amLive Stream
Informa Connect Welcome and Chairperson's Opening Remarks: Main Stage
- Neil Falkingham - Senior Vice President, Chief Compliance Officer, GSK
8:40am - 9:40amLive Stream
Becoming High-Impact Business Partners: Strategic Relationships with Internal Stakeholders
- Moving past us-versus-them mindset: the future of collaboration, embed systems and ways of working for success
- What do Commercial teams want from Compliance and vice versa to be effective
- How can strategic relationships with internal stakeholders be optimized in different-sized pharmaceutical organizations?
- How can Compliance ensure the business owns its programs, accountable for enforcement, and how can they work together more strategically?
- Robert Ladd - Senior Vice President, Chief Ethics & Compliance Officer, Gilead Sciences
- Jill Fallows Macaluso - Corporate Vice President & Chief Compliance Officer, Novo Nordisk
- Gbubemi Nanna - Vice President, Area Commercial Lead - Mid West, Cardiometabolic Sales, Novo Nordisk
- Francisco Ribeiro - VP, Associate Compliance Officer, Oncology Global Therapeutics OEC, AbbVie
- Marci Juneau - Partner, Helio Health Group
9:40am - 10:40amLive Stream
Global CCO Spotlight: An International Dialogue and Discussion on Compliance and Risk
- Practical perspectives on risk management in a dynamic enforcement environment
- Values-based vs. rules-based approaches to compliance in the global context
- Organizing global teams: what works and what doesn’t
- Establishing compliance standards across varied geographies
- Anisa Dhalla - Vice President and Chief Ethics and Compliance Officer, UCB
- Jennifer McGee - Former Senior Vice President, Global Chief Ethics and Compliance Officer, Otsuka Pharmaceutical Companies
- Leonardo Silva - Vice President, Chief Compliance & Privacy Officer, Ferring Pharmaceuticals
- Tara McCarthy - Co-Founder and Partner, Dovetail Consulting Group
10:40am - 11:10am
Networking Break
Showing 1 of 1 Streams
Main Stage
11:10am - 12:10pmLive Stream
Law Firm Benchmarking Session - Chairs of Life Science Groups in Law Firms
- What are the next generation of enforcement cases?
- Where are companies focusing? Where are we seeing trends?
- Insiders’ insight: investigations and types of issues companies are struggling with
- Creative strategies being employed to increase market share: key risks and mitigation strategies
- How are you seeing your clients utilizing outside counsel and has the role of outside counsel changed?
- Lisa LeCointe-Cephas - Partner, Compliance & Investigations, Global Co-Chair, Life Sciences Sector, DLA Piper
- George Karavetsos - White Collar Defense, Compliance, and Investigations Practice Group Leader, Buchanan Ingersoll & Rooney
- Meenakshi Datta - Partner, Sidley Austin LLP
- Scott Liebman - Partner and Chair, FDA Regulatory & Compliance; Co-Chair, Life Sciences, Sheppard Mullin Richter & Hampton
- Kip Ebel - Partner/Principal, EY Americas - Forensics Consumer & Health Industry Group Leader, Ernst & Young
12:10pm - 1:10pmLive Stream
Industry Pioneers – Progress on the Adoption of AI and Practical Impact on Compliance Thinking
- How are organizations managing the expanding responsibilities and priorities in the era of AI?
- Balancing and integrating your core company mission alongside the need to keep your organization safe whilst embracing AI implementation
- Analyzing the impact of AI implementation on Compliance roles and departments
- Implications for your workforce and the effects on culture and staffing
- Keeping pace with fast-moving technological advances: leveraging your foundation of ethics in the absence of robust rules and regulations
- Franziska Janorschke - Global Head Data Privacy, Digital & AI Compliance; Ethics, Risk & Compliance, Novartis International AG
- Daryl Kreml - Former Chief Enterprise Risk and Compliance Officer, Sage Therapeutics
- Natasha Trifun - Head of Compliance for R&D, Global Medical and Global Functions, Alexion, AstraZeneca Rare Disease
- Andy Miller - Senior Vice President, Analytics and AI, Case IQ
1:10pm - 2:40pm
Networking Lunch
Power Hour - This interactive format is designed to ignite fresh ideas and drive industry collaboration
Showing 4 of 4 Streams
Power Hour A
Power Hour B
Power Hour C
Power Hour D
2:40pm - 3:40pm
SOFT SKILL LAB Practical Communication Strategies to Effectively Publicize and Supercharge Your Compliance Program to Cultivate a Culture of Compliance
- Key components of a successful communication program
- How to incorporate marketing-style communications and launch sophisticated campaigns
- What can we learn from brand marketing to amplify your message?
- Applying behavioral psychology tools to promote your message
- Alyssa Zeff - VP and Head, the bswift Engagement Agency
2:40pm - 3:40pm
Training Effectiveness
- Practical tools to measure the effectiveness of training
- Tips for avoiding information overloaded
- How do you know what individuals have retained: demonstrating Compliance learning in practice
- Metrics tracking when staff complete training and whether training is factored into performance management systems
- Brian Miller - Senior Director, Global Compliance & Ethics Policies, Learning, and Engagement, Otsuka
- Sherri Borgal - Director, Ethics & Compliance at Alnylam, Alnylam
- Daniel O’Connor - Senior Vice President, NXLevel Compliance
2:40pm - 3:40pmLive Stream
Compliance Investigations
- Practical tools and tips for handling difficult investigations and joint working with Legal/HR
- How to conduct them?
- Who conducts them?
- Should they always be done under privilege?
- How are sanctions determined?
- How are investigation outcomes shared with the organization?
- Tara Kennedy - Senior Director Ethics & Compliance, North America, Apellis Pharmaceuticals
- Audrey Perlow - Senior Director, North American Healthcare Compliance, Grifols
- Gavin Proudley - Head of Third Party Risk Proposition, Dow Jones Risk & Compliance, Dow Jones
2:40pm - 3:40pm
The Fundamentals of Good Data: Preliminary Steps to Getting the Most Out of Your Analytics
Practical considerations for meeting OIG, CMS and DOJ expectations for data access, knowledge and assessments.
Who: Internal resources to engage, train and help influence change
What: Practical considerations for gathering data from field interactions to system reports
Where: Key source systems and tools, configuration best practices, and control considerations
Why: Challenges with data quality, completeness, and integrity
How: Dos and Don’ts of Auditing and Analytics
- Cristina List - Director, Compliance Advisory Services, MedPro Systems
3:40pm - 4:10pm
Networking Break
Topic Intensives - Delve into the detail with practical scenarios and hands on approaches
Showing 3 of 3 Streams
Transparency in Practice
Managing Privacy and Data Risks
AI in Practice
4:10pm - 4:55pmLive Stream
Speaker Bureau Programs - Benchmarking Session
- Sharing practical takeaways from speaker program benchmarking
- Analyzing the key components of successful speaker programs
- Practicalities of meeting restrictions and regulations to ensure compliant speaker programs
- Best practice for designing policies to ensure the success and integrity of your speaker program
- Michael Young - Senior Director, Potomac River Partners
- Adam Oakley - Senior Director, Potomac River Partners
4:55pm - 5:40pmLive Stream
HCP Perspective on Transparency Reporting
- Fresh perspective on vendor interactions with HCPs
- Policies and guidelines from HCP perspective on how they are allowed to engage with pharma, speaker bureau, food & beverage, speaking consulting
- How to work together to maximize engagement in a compliant way
- Tanya White - System Compliance Operations Officer, Yale New Haven Health, Yale University
- Elizabeth Valentino - Senior Compliance & Conflicts of Interest Specialist, Yale New Haven Health
- John Kelly - Partner and Chair, Healthcare Department and Industry Practice, Barnes & Thornburg
4:10pm - 4:55pm
Compliance’s Role in Effective Data Management and Governance
- As data risks outside of privacy evolve, how does Compliance navigate an organization’s evolving data risk landscape?
- Other data risks to consider: data transfer, storage, data set management, data visibility, data platform considerations, data reporting, and data sharing across R&D, Medical, and Commercial functions
- Compliance’s role in data management and governance of risk
- Gina Nese - Vice President Associate General Counsel Compliance and Privacy Officer, Align Technology
- Ryan Bonistalli - Executive Director, Compliance, Ultragenyx
- Jeff Hyre - Regional VP, Global Relay
4:55pm - 5:40pm
Compliance’s Role in Evolving Privacy Regulation Landscape
- How do you set up privacy programs considering the varying privacy requirements and an ever-changing landscape?
- As privacy considerations grow for your business, where does it sit and how do you operationalize it? Compliance vs. Legal department vs. independent privacy officer?
- Joseph Philipose - Senior Vice President, Chief Ethics and Compliance Officer, Emergent BioSolutions
- Christie Dougherty - Associate Director, Ethics & Compliance, Global & US Privacy, Alnylam Pharmaceuticals
4:10pm - 4:55pm
AI Governance and Risk Assessment in your Organization
- Practical approaches and use cases to evaluating current and emerging risks associated with AI
- Who should to have a seat at the table to assess and approach AI governance and risk assessment
- Considerations for developing and refining Policies to reflect AI
- How to develop an approach to governing AI, enterprise models, and how an organization operationalizes AI governance
- Jeanille Gatta - Compliance Director, AstraZeneca
- Fred Medick - Assistant General Counsel, Genentech
- Jim Dawson - Vice President, Compliance Solutions, qordata
4:55pm - 5:40pm
How to Leverage AI in Compliance Function
- Expectations from the Compliance function in AI-enabled companies, and their implications
- Current AI initiatives in Compliance - benefits, challenges, and lessons learnt
- The path forward - exciting possibilities and key risks
- Top tips for success
- Christine Zettlemoyer - Senior Vice President, Global Head of Compliance, Risk, and Data Privacy Program, Genmab
- Christian Dingler - Executive Director, Risk Management and Program Effectiveness, Insmed
- Gaurav Sharma - Vice President, Product Management, RLDatix Life Sciences
5:40pm - 5:45pm
Close of Day Two
Filter
Streams
Formats
Choose Day